The latest issue of our magazine Nordic Life Science is out, don’t forget to sign up for a subscription!
This issue includes a special report on obesity, including an exclusive interview with professor Jens Juul Holst, discoverer of the now world-famous GLP-1, other Nordic obesity solutions beyond GLP-1, patient perspectives, investor perspectives, a market overview, and in-depth science articles about the field.
Another theme in this issue is rare diseases, an area that has undergone a minor revolution in recent decades, and where Nordic collaboration, as well as patient perspectives and involvement, are crucial. In addition, it includes an exclusive interview with Anna Falk, Head of Lund University’s Center for Advanced Therapies, and you may learn more about the importance of embracing legalese as a drug developer.
This, and much more!
